Fulgent Genetics, Inc. FLGT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $71.14M-3.2% | $83.34M+9.3% | $84.07M+17.2% | $81.8M+15.2% | $73.46M+13.9% | ||
| $49.65M+10.0% | $50.75M+14.4% | $48.56M+8.0% | $47.37M+6.4% | $45.12M+6.5% | ||
| $21.49M-24.2% | $32.58M+2.3% | $35.51M+32.7% | $34.44M+30.0% | $28.35M+28.2% | ||
| 30.2%-8.4pp | 39.1%-2.7pp | 42.2%+4.9pp | 42.1%+4.8pp | 38.6%+4.3pp | ||
| $14.18M+14.4% | $14.17M+17.0% | $13.86M+17.6% | $13.48M0.0% | $12.4M+8.4% | ||
| $12.22M+44.4% | $10.98M+15.1% | $11.64M+27.6% | $12.29M+42.9% | $8.47M-5.8% | ||
| $27.68M+9.5% | $41.65M+71.1% | $23.34M+11.4% | $26.39M+23.8% | $25.29M+17.7% | ||
| $56.11M+16.6% | $68.82M+43.4% | $50.86M+16.0% | $54.15M+19.3% | $48.14M+9.7% | ||
| -$34.62M-74.9% | -$36.24M-125% | -$15.35M+10.1% | -$19.71M-4.3% | -$19.8M+9.2% | ||
| -48.7%-21.7pp | -43.5%-22.3pp | -18.3%+5.5pp | -24.1%+2.5pp | -26.9%+6.9pp | ||
| $17K+21.4% | $16K— | $28K+100% | $17K-32.0% | $14K+106% | ||
| $8.64M+7.1% | $6.96M-13.9% | $7.84M+640% | -$1.81M-123% | $8.07M+5.9% | ||
| -$25.98M-122% | -$29.27M-264% | -$7.51M+59.5% | -$21.52M-91.9% | -$11.72M+17.3% | ||
| -$704K-500% | -$5.62M-203% | -$683K+82.2% | -$2.26M-6.5% | $176K+154% | ||
| -$24.83M-115% | -$23.42M-298% | -$6.61M+54.9% | -$18.96M-118% | -$11.53M+14.4% | ||
| -34.9%-19.2pp | -28.1%-20.4pp | -7.9%+12.6pp | -23.2%-10.9pp | -15.7%+5.2pp | ||
| -$0.80-116% | -$0.76-300% | -$0.21+56.3% | -$0.62-114% | -$0.37+17.8% | ||
| -$28.62M-106% | -$30.13M-203% | -$9.31M+16.6% | -$13.66M-7.1% | -$13.88M+8.3% | ||
| -40.2%-21.3pp | -36.2%-23.1pp | -11.1%+4.5pp | -16.7%+1.3pp | -18.9%+4.6pp | ||
| -$34.62M-74.9% | -$36.24M-125% | -$15.35M+10.1% | -$19.71M-4.3% | -$19.8M+9.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Fulgent Genetics, Inc.'s revenue?
- Fulgent Genetics, Inc. (FLGT) generated $320.3M in revenue over the trailing twelve months, up 9.5% year over year.
- Is Fulgent Genetics, Inc. profitable?
- Fulgent Genetics, Inc. is not currently profitable: it reported a net loss of $73.8M over the trailing twelve months, a -23.0% net margin.
- What are Fulgent Genetics, Inc.'s profit margins?
- Gross margin is 38.7% and operating margin is -33.1%, with a -23.0% net margin.
- What is Fulgent Genetics, Inc.'s earnings per share?
- Fulgent Genetics, Inc.'s diluted EPS over the trailing twelve months is $-2.39.
- Where does Fulgent Genetics, Inc.'s income statement data come from?
- Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
